The Effects of Low Levels of Dystrophin on Mouse Muscle Function and Pathology
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Effects of Low Levels of Dystrophin on Mouse Muscle Function and Pathology
Authors
Keywords
-
Journal
PLoS One
Volume 7, Issue 2, Pages e31937
Publisher
Public Library of Science (PLoS)
Online
2012-02-17
DOI
10.1371/journal.pone.0031937
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
- (2011) Sebahattin Cirak et al. LANCET
- Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD)
- (2011) V.D. Nadarajah et al. NEUROMUSCULAR DISORDERS
- Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy
- (2011) Nathalie M. Goemans et al. NEW ENGLAND JOURNAL OF MEDICINE
- New insights in gene-derived therapy: the example of Duchenne muscular dystrophy
- (2010) Annemieke Aartsma-Rus et al. Annals of the New York Academy of Sciences
- Physiological Characterization of Muscle Strength With Variable Levels of Dystrophin Restoration in mdx Mice Following Local Antisense Therapy
- (2010) Paul S Sharp et al. MOLECULAR THERAPY
- Timeline of cardiac dystrophy in 3-18-month-old MDX mice
- (2010) Christel Van Erp et al. MUSCLE & NERVE
- A 3 months mild functional test regime does not affect disease parameters in young mdx mice
- (2010) Maaike van Putten et al. NEUROMUSCULAR DISORDERS
- Clinical and genetic characterization of manifesting carriers of DMD mutations
- (2010) Payam Soltanzadeh et al. NEUROMUSCULAR DISORDERS
- Dystrophin Immunity in Duchenne's Muscular Dystrophy
- (2010) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aminoglycoside-induced mutation suppression (stop codon readthrough) as a therapeutic strategy for Duchenne muscular dystrophy
- (2010) Vinod Malik et al. Therapeutic Advances in Neurological Disorders
- Xist gene regulation at the onset of X inactivation
- (2009) Claire E Senner et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- In vivocomparison of 2′-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping
- (2009) Hans A. Heemskerk et al. JOURNAL OF GENE MEDICINE
- Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study
- (2009) Maria Kinali et al. LANCET NEUROLOGY
- Preclinical drug trials in themdxmouse: Assessment of reliable and sensitive outcome measures
- (2009) Christopher F. Spurney et al. MUSCLE & NERVE
- Blastocyst Injection of Wild Type Embryonic Stem Cells Induces Global Corrections in Mdx Mice
- (2009) Elizabeth Stillwell et al. PLoS One
- Preservation of Muscle Force in Mdx3cv Mice Correlates with Low-Level Expression of a Near Full-Length Dystrophin Protein
- (2008) Dejia Li et al. AMERICAN JOURNAL OF PATHOLOGY
- Prevention of Dystrophin-Deficient Cardiomyopathy in Twenty-One-Month-Old Carrier Mice by Mosaic Dystrophin Expression or Complementary Dystrophin/Utrophin Expression
- (2007) Brian Bostick et al. CIRCULATION RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now